This is a vital segment of the research study as it provides market insights relating to the growth of the Stem Cell Therapy market at both the country as well as regional level. The researchers estimate the market growth in different regions and countries by assessing both value and volume. They accurately analyze the revenue, price, CAGR, consumption, sales, and other aspects relevant to the regional markets studied in the report. The global Stem Cell Therapy Market is expected to reach USD 3,693.6 Million by 2027, according to a new report by Emergen Research.
You Can
Download Free Sample PDF Copy of Stem Cell Therapy Market at https://www.emergenresearch.com/request-sample/83
Key
Highlights From The Report
Allogeneic Stem Cell Therapy dominated the segment of stem
cell therapy by type. Allogeneic transplant is recommended to those patients
who have a high risk of relapse even after successful treatment with
chemotherapy. An increase in the occurrence of cancer relapse has propelled the
demand for the segment. The segment has an added advantage as they manufacture
their own immune stem cells. These cells have the potential to kill cancer
cells that are left behind after high-dosage treatment with cytotoxic drugs.
The enhancement in the cutting-edge orthopedic treatments
involving stem cell therapy has helped in the relief of pain and also in
recovery time. It eliminates the need for medication and invasive surgery, such
as joint replacements leading to increased mobility. The regenerative medicine
segment is anticipated to grow with a CAGR of 36.4% during the forecast period.
Hospital held a larger market share due to the rising
preference for stem cell therapies in these institutions. Hospitals are
affiliated with academic institutes and research laboratories for the
development of new therapies. Hospitals implement the latest discoveries.
North America will account for the largest share of the
global stem cell market. The major contribution will be from the United States,
and the region will witness high growth owing to the increased amount of
funding by the private as well as government firms for clinical trials.
Key participants include Virgin Health Bank, Celgene
Corporation, ReNeuron Group plc, Biovault Family, Precious Cells International
Ltd., Mesoblast Ltd., Opexa Therapeutics, Inc., Caladrius, Neuralstem, Inc.,
and Pluristem, among others.
Type
Outlook (Revenue, USD Million; 2017-2027)
Allogeneic Stem Cell Therapy
Autologous Stem Cell Therapy
Application
Outlook (Revenue, USD Million; 2017-2027)
Regenerative Medicine
Orthopedics
Neurology
Hematology stem cells
Soft tissue injuries
Cardiovascular and myocardial infarction-based
Oncology
Diabetes
Liver Disorder
Others
Drug discovery & development
End-User
Outlook (Revenue, USD Million; 2017-2027)
Clinics
Hospitals
Others
Regional
scope: North America; Europe; Asia Pacific; Central & South
America; MEA
Read
more@ https://www.emergenresearch.com/industry-report/stem-cell-therapy-market
Table
of Content
Chapter 1. Methodology & Sources
1.1. Market
Definition
1.2. Research
Scope
1.3. Methodology
1.4. Research
Sources
1.4.1.
Primary
1.4.2.
Secondary
1.4.3. Paid
Sources
1.5. Market
Estimation Technique
Chapter 2. Executive Summary
2.1. Summary
Snapshot, 2019-2027
Chapter 3. Key Insights
Chapter 4. Stem Cell Therapy Market Segmentation &
Impact Analysis
4.1. Stem Cell
Therapy Market Material Segmentation Analysis
4.2. Industrial
Outlook
4.2.1. Market
indicators analysis
4.2.2.
Market drivers analysis
4.2.2.1. Growing demand for growing medicinal application
4.2.2.2. Rising legalization of Stem Cell Therapy
4.2.2.3. Technological advancement in product invention
4.2.3.
Market restraints analysis
4.2.3.1. The complex regulatory framework for the usage of Stem Cell
Therapy
4.3. Technological
Insights
4.4. Regulatory
Framework
4.5. Porter’s Five
Forces Analysis
4.6. Competitive
Metric Space Analysis
4.7. Price trend
Analysis
4.8. Covid-19
Impact Analysis
Continued…
No comments:
Post a Comment